Acute Lymphoblastic Leukemia News and Research

RSS
Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells, the cells in the body that normally fight infections. There are two main types of white blood cells-lymphoid cells and myeloid cells. ALL affects lymphoid cells.
Study reveals how two separate DNA changes may predict aggressive childhood leukemias

Study reveals how two separate DNA changes may predict aggressive childhood leukemias

Small molecular changes can have dramatic impact on the CAR T cell function

Small molecular changes can have dramatic impact on the CAR T cell function

Researchers uncover a key genetic culprit in the development of acute lymphoblastic leukemia

Researchers uncover a key genetic culprit in the development of acute lymphoblastic leukemia

Engineered safety switch reduces CAR-T immunotherapy-related side effects

Engineered safety switch reduces CAR-T immunotherapy-related side effects

Yale scientists discover novel metabolic gatekeeper mechanism for leukemia

Yale scientists discover novel metabolic gatekeeper mechanism for leukemia

Researchers create molecular ON-OFF switches to regulate CAR T cell activity

Researchers create molecular ON-OFF switches to regulate CAR T cell activity

Mice infused with CD5-deleted CAR T cells showed significant reduction in tumor size

Mice infused with CD5-deleted CAR T cells showed significant reduction in tumor size

Researchers target pathogenic T cells that could lead to new immunotherapy treatments

Researchers target pathogenic T cells that could lead to new immunotherapy treatments

Study shows how cancer remodels human chromosomes for its own purposes

Study shows how cancer remodels human chromosomes for its own purposes

Inherited variation in GATA3 gene associated with relapse in children with leukemia

Inherited variation in GATA3 gene associated with relapse in children with leukemia

Clinical trial shows CAR-T cell therapy can be used for treating Hodgkin lymphoma

Clinical trial shows CAR-T cell therapy can be used for treating Hodgkin lymphoma

Josep Carreras Institute creates spin-off to develop CAR-T based therapies for leukemia

Josep Carreras Institute creates spin-off to develop CAR-T based therapies for leukemia